Investor Video Call // March 5, 2025 // 2:00 p.m. CET

Q4/FY 2024 Results

Bayer meets adjusted guidance and takes decisive action to tackle challenges 

View Press Release
finger tipping at tablet 1

Speakers

Anderson_Portrait_neutral.jpg,default.jpg
Bill Anderson

Chairman

Wolfgang Nickl,default.jpg
Wolfgang Nickl

Finance

Oelrich_Portrait_neutral.jpg,default.jpg
Stefan Oelrich

Pharmaceuticals

Santos_Portrait_neutral.jpg,default.jpg
Rodrigo Santos

Crop Science

Triana_Portrait_neutral.jpg,default.jpg
Julio Triana

Consumer Health

Board of Management of Bayer AG
businessman_talking_on_phone_1 (1).jpg

Investor Services

Subscribe to our newsletter for regular financial updates or contact our team directly via e-mail for any individual inquiries.

Newsletter SubscriptionE-Mail Investor Relations